Skip to content

The evaluation of effectiveness of a topical formulation of linseed oil in patients with knee osteoarthritis

Comparison of effectiveness of a topical formulation of linseed oil with Diclofenac gel in patients with mild to moderate knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017082011341N9
Enrollment
94
Registered
2017-09-19
Start date
2017-10-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Gonarthrosis

Interventions

Intervention 1: linseed oil,three times a day on,topically on painful knee. Intervention 2: Diclofenac gel 1%,three times a day,topically on painful knee.
Treatment - Drugs
Placebo
linseed oil,three times a day on,topically on painful knee
Diclofenac gel 1%,three times a day,topically on painful knee

Sponsors

Vice chancellor for research,Fasa University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the age between 35-70 years;at least having pain in one knee for past 3 months;recognition of osteoarthritis by the doctor according to American college of rheumatology classification criteria; recognition of grade I to III osteoarthritis by the doctor according to Kellegren-Lawrence(K-L)grading scale;absence of any congenital abnormality in lower extremity;written informed consent for inclusion. Exclusion Criteria: sensitivity and allergy to linseed or diclofenac gel or acetaminophen;skin disease in knee;patients with secondary osteoarthritis due to other bone joint disorders like rheumatoid arthritis, gout, infected arthritis, metabolic arthritis, traumatic arthritis; joint replacement; oral and topical use of corticostreoid in past 14 days;knee corticosteroid or hyaluronic acid injection in the past 90 days; other articular corticosteroid or hyaluronic acid injection in the past 1 month;topical or oral usage of painkillers in past 3 days;concomitant use of glucosamin or chondroitin sulfate;pregnancy and lactation; alcohol or drug addiction; disability to cooperate in filling the forms (cognitive or language disorder); patients with active peptic ulcer diseases and inflammatory bowl disease(IBD);BMI = 35 kg/m^2;physical modality in knee joint in past 2 weeks like physical therapy,acupuncture and Transcutaneous Electrical Nerve Stimulator (TENS).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Visual analogue scale. Timepoint: At the beginning of intervention,after2 weeks then after 4 weeks from the beginning of intervention. Method of measurement: Asking the patients.

Secondary

MeasureTime frame
Function in daily living (ADL). Timepoint: At the beginning of intervention,after 2 weeks then 4 weeks afterthe beginning of intervention. Method of measurement: KOOS questionnaire.;Other Symptoms. Timepoint: At the beginning of intervention,after 2 weeks then 4 weeks afterthe beginning of intervention. Method of measurement: KOOS questionnaire.;Pain. Timepoint: At the beginning of intervention,after 2 weeks then 4 weeks afterthe beginning of intervention. Method of measurement: KOOS questionnaire.;Function in sport and recreation(Sport/Rec). Timepoint: At the beginning of intervention,after 2 weeks then 4 weeks afterthe beginning of intervention. Method of measurement: KOOS questionnaire.;Knee related quality of life(QOL). Timepoint: At the beginning of intervention,after 2 weeks then 4 weeks afterthe beginning of intervention. Method of measurement: KOOS questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Alireza Askari

Fasa Universityof Medical Sciences

aaskari60@yahoo.com+98 71 5335 0994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026